Results 21 to 30 of about 3,973 (220)

Effects of open-label placebos and self-monitoring in skin-picking disorder: a randomized crossover trial [PDF]

Frontiers in Psychiatry
BackgroundSymptom reduction in skin-picking disorder (SPD) has previously been demonstrated using deceptive placebo treatments. However, to date, no study has investigated the effects of open-label placebos (OLPs) in this context.MethodFifty-two ...
Anne Schienle, Albert Wabnegger, Sandra Tanzmeister   +2 more
doaj   +2 more sources

The effect of open-label placebo on anxiety, cortisol, and pain levels in children with procedural pain [PDF]

Frontiers in Pediatrics
PurposeNeedle-related procedures are painful experiences for hospitalized children and are associated with anxiety, pain and stress. Open-label placebos (i.e., placebos administered honestly as an inert substance) have recently been shown to be as ...
Anna Lena Friedel, Tim Szallies, Jana Oberlohmann, Leonie Peters, Sven Benson, Sven Benson, Manfred Schedlowski, Manfred Schedlowski, Eva Tschiedel   +8 more
doaj   +2 more sources

Open-Label-Placebos can reduce pain, but not indigestion during gluten challenge in chronic pain patients [PDF]

Frontiers in Psychology
BackgroundDietary interventions have become a management tool for chronic pain conditions over the past few decades. Certain diets, such as gluten-free diets, are perceived as particularly beneficial by patients, although there is no evidence to support ...
Lena Paschke-Dahl, Regine Klinger
doaj   +2 more sources

Efficacy of open-label placebos for premenstrual syndrome: a randomised controlled trial. [PDF]

BMJ Evid Based Med
ObjectiveTo investigate the efficacy and safety of open-label placebos (OLP) in premenstrual syndrome (PMS).DesignRandomised controlled trial.SettingSwitzerland, 2018–2020.Participants150 women (18–45 years of age) with PMS or premenstrual dysphoric disorder.InterventionRandom assignment (1:1:1) to treatment as usual (TAU), OLP without treatment ...
Frey Nascimento A, Gaab J, Degen B, Rytz M, Holder A, Sezer D, Buergler S, Meyer AH, Kirsch I, Kossowsky J, Locher C.   +10 more
europepmc   +3 more sources

Reducing Emotional Distress with Open-Label Placebos: Assessing the Role of Motor Engagement in Pill Consumption [PDF]

Behavioral Sciences
It has been posited that ingesting a pill constitutes a pivotal action that facilitates the effects of open-label placebos (OLPs: placebos honestly prescribed).
Anne Schienle, Wolfgang Kogler
doaj   +2 more sources

Neural correlates of expected and perceived treatment efficacy concerning open-label placebos for reducing emotional distress

Brain Research Bulletin
Background: Treatment expectations for open-label placebos (OLPs) - placebos prescribed transparently - refer to what a person anticipates will happen as a result of taking the placebo.
Anne Schienle, Albert Wabnegger
doaj   +3 more sources

Treating Pain With Open-Label Placebos: A Qualitative Study With Post-Surgical Pain Patients [PDF]

Journal of Pain, 2021
Michael H Bernstein, Nathaniel Fuchs, Charlotte Blease   +2 more
exaly   +2 more sources

A systematic qualitative review of ethical issues in open label placebo in published research [PDF]

Scientific Reports
Open-label placebos (OLPs), which are transparently administered inert treatments, have gained increasing attention in the research community. They have the potential to harness placebo effects without deceiving the patient. The purpose of this study was
Mélina Richard, Michael Bernstein, Jens Gaab, Bernice Elger   +3 more
doaj   +2 more sources

Talking placebo: a qualitative study of patients’ attitudes toward open-label placebo implementation into clinical practice [PDF]

Frontiers in Psychology
BackgroundFor more than a decade, studies have supported the efficacy and safety of placebos without deception—so-called open-label placebos (OLPs)—to harness placebo effects in primary care while aligning with key ethical principles.
Antje Frey Nascimento, Berfin Bakis, Jens Gaab, Tobias Schneider, Athina Papadopoulou, Athina Papadopoulou, Milena Ritter, Michael H. Bernstein, Michael H. Bernstein, Charlotte R. Blease, Charlotte R. Blease, Cosima Locher, Cosima Locher   +12 more
doaj   +2 more sources

Public and professional attitudes towards deceptive and open-label placebo in functional neurological disorder and wider neurological practice [PDF]

BMJ Neurology Open
Background Placebo effects are powerful and have been suggested to be particularly relevant in certain neurological conditions, including functional neurological disorder (FND).Methods A survey on attitudes towards and current practice of deceptive ...
Mark J Edwards, Kailash P Bhatia, Anne-Catherine M L Huys   +2 more
doaj   +2 more sources